HighTower Advisors’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.7K Buy
+10,031
New +$8.14K ﹤0.01% 3811

Other funds holding ONCY

HighTower Advisors's ONCY Position: Q3 2026 in Review

HighTower Advisors opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 10,031 shares worth $6.7K. The stake represents ﹤0.01% of the portfolio and ranks #3811 among its holdings.

64 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • HighTower Advisors held 10,031 shares of Oncolytics Biotech worth $6.7K as of Q3 2026.
  • Oncolytics Biotech was a new HighTower Advisors position in Q3 2026.
  • Oncolytics Biotech made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3811 holding.
  • 64 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.